COVID-19 and Breast Cancer in Brazil.
Int J Public Health
; 68: 1605485, 2023.
Article
in English
| MEDLINE | ID: covidwho-2278498
ABSTRACT
Objectives:
This study aimed to evaluate COVID-19 effects on breast cancer screening and clinical stage at diagnosis in patients of 50-69 years of age receiving care within the public healthcare network (SUS) in 2013-2021 in Brazil and its macro-regions.Methods:
This ecological study used Poisson regression to analyze trends in screening and staging. A secondary database was formed using SUS sources outpatient data system of the SUS network and Oncology-Brazil Panel.Results:
There was a reduction in screening, with an annual percent change of -5.9 (p < 0.022). The number of notified cases fell by 31.5% in 2020-2021 compared to 2018-2019. There was a 10.7% increase in the proportion of stage III/IV cases (p < 0.001) in 2020-2021 compared to 2013-2019, now surpassing the number of cases of early stage breast cancer.Conclusion:
COVID-19 led to a reduction in breast cancer screening and an expressive increase in advanced tumors in users of the public healthcare network. Urgent interventions in public policies are required as the negative effects of the pandemic on the diagnosis/treatment of breast cancer are becoming apparent even earlier than expected.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
COVID-19
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Female
/
Humans
Country/Region as subject:
South America
/
Brazil
Language:
English
Journal:
Int J Public Health
Journal subject:
Public Health
Year:
2023
Document Type:
Article
Affiliation country:
Ijph.2023.1605485
Similar
MEDLINE
...
LILACS
LIS